OncoTargets and Therapy · 2014 · 20 citations · 33 references
The results of this meta-analysis suggest that RUNX3 hypermethylation is associated with an increased risk of CRC, increased risk of progression of CRC, and a poorer CRC survival rate. RUNX3 hypermethylation, which induces the inactivation of RUNX3 gene, plays an important role in colorectal carcinogenesis, high levels of MSI, as well as CRC progression and development.
33
Bias in meta-analysis detected by a simple, graphical test
Matthias Egger, George Davey Smith, Martin Schneider et al. · BMJ · 1997 · 54.3K citations · Full text
Meta-analysis in clinical trials
Rebecca DerSimonian, Nan M. Laird · Controlled Clinical Trials · 1986 · 38.5K citations
Meta-analysis, Clinical Trial Management, Clinical Trials +6
Causal Relationship between the Loss of RUNX3 Expression and Gastric Cancer
Qing-Lin Li, Kosei Ito, Chohei Sakakura et al. · Cell · 2002 · 1K citations · Full text